Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00795418
What this trial is testing

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

Who this might be right for
Alzheimer's Disease
Novartis 31
Not applicableStudy completedNCT05150990
What this trial is testing

Technology and Family Thriving Study

Who this might be right for
Alzheimer DiseaseDementiaCaregiver Burnout+4 more
University of California, Santa Barbara 186
Not applicableStudy completedNCT05721482
What this trial is testing

Stress and Hypertension in Dementia Caregivers

Who this might be right for
HypertensionStress, Psychological
Ohio State University 28
Not applicableStudy completedNCT04938648
What this trial is testing

Aligning Medications With What Matters Most

Who this might be right for
PolypharmacyAlzheimer Disease and Related Dementias
Johns Hopkins University 138
Not applicableUnknownNCT03977025
What this trial is testing

Alzheimer Biomarkers on CSF of Elderly Patients Undergoing Surgery

Who this might be right for
Alzheimer Disease
University of Chile 30
Not applicableStudy completedNCT01123018
What this trial is testing

Screening for Memory Studies

Who this might be right for
Memory LossMemory DeficitsDementia+1 more
John Wesson Ashford Jr 1
Large-scale testing (Phase 3)Ended earlyNCT04339413
What this trial is testing

Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 116
Not applicableUnknownNCT02195596
What this trial is testing

Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.

Who this might be right for
Alzheimer Disease
Basque Health Service 80
Early research (Phase 1)Looking for participantsNCT07218081
What this trial is testing

A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.

Who this might be right for
Alzheimer Dementia (AD)
Augusta University 12
Large-scale testing (Phase 3)Ended earlyNCT02477800
What this trial is testing

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 1,653
Early research (Phase 1)Ended earlyNCT03307993
What this trial is testing

Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 3
Not applicableStudy completedNCT07307872
What this trial is testing

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more
Amoneta Diagnostics SAS 150
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350
Testing effectiveness (Phase 2)Study completedNCT00359944
What this trial is testing

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sumitomo Pharma America, Inc. 171
Not applicableLooking for participantsNCT03761381
What this trial is testing

OCT Angiography and NRAI in Dementia

Who this might be right for
Alzheimer DiseaseDementiaMild Cognitive Impairment
Oregon Health and Science University 20
Not applicableNot Yet RecruitingNCT07730671
What this trial is testing

PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers

Who this might be right for
Subjective Cognitive Decline (SCD)
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 121
Large-scale testing (Phase 3)Study completedNCT00191009
What this trial is testing

Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 124
Not applicableLooking for participantsNCT07341009
What this trial is testing

Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Time Perception
University Hospital, Caen 40
Early research (Phase 1)Looking for participantsNCT06945614
What this trial is testing

Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation

Who this might be right for
Healthy Volunteer Study
General Biophysics LLC 16
Testing effectiveness (Phase 2)Ended earlyNCT03702816
What this trial is testing

The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)

Who this might be right for
Alzheimer DiseaseParkinson DiseaseInflammation
Aaron Ritter, MD 24
Next Page